Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740634 · ClinicalTrials.gov registry record · NA
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
A NA study of Alzheimer Disease and Alzheimer Disease, Early Onset, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT02740634: Active NA study of Alzheimer Disease and Alzheimer Disease, Early Onset, sponsored by Mayo Clinic.
NCT02740634 is a NA study of Alzheimer Disease and Alzheimer Disease, Early Onset that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02740634, a NA study of Alzheimer Disease and Alzheimer Disease, Early Onset, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a neuroimaging study designed to learn more about amyloid and tau burden in the brain of patients with typical and atypical Alzheimer's Disease and how burden may change over a one year period.
Conditions Studied
Interventions
- DRUG F-18 AV 1451
- DRUG C-11 PiB
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-05 |
| Est. Completion | 2026-03 |
| Phase | NA |
What the registry record for NCT02740634 still lists
NCT02740634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower).
The record links to 8 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which F-18 AV 1451 is the first listed.
NCT02740634 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02740634 about?
NCT02740634 is a clinical study titled "Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study". This is a neuroimaging study designed to learn more about amyloid and tau burden in the brain of patients with typical and atypical Alzheimer's Disease and how burden may change over a one year period.
What is the current status of trial NCT02740634?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2016-05. Estimated completion is 2026-03.
What conditions does trial NCT02740634 study?
This clinical trial studies the following conditions: Alzheimer Disease, Alzheimer Disease, Early Onset, Amnestic Mild Cognitive Disorder, Logopenic Progressive Aphasia (LPA), Posterior Cortical Atrophy(PCA).
What interventions are being tested in trial NCT02740634?
The interventions under investigation include: F-18 AV 1451 (DRUG), C-11 PiB (DRUG).
Who is sponsoring clinical trial NCT02740634?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02740634 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02740634's enrollment target sits among peer trials
60 187th of 306 higher than 108 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia